Selected research
Industry Research
Sophocarpidine Industry Research Report 2026
Market perspective
The global Sophocarpidine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sophocarpidine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sophocarpidine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sophocarpidine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sophocarpidine include Fujie Pharmaceutical, Indena, Jiangsu Tiansheng Pharmaceutical, QHL Pharma, Selco Wirkstoffe Vertriebs GmbH, Select Botanical, TIANSHAN Pharmaceuticals, Hubei Zhongliao Chemical Co., LTD and Tiansheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sophocarpidine market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sophocarpidine Market by Company
Fujie Pharmaceutical
Indena
Jiangsu Tiansheng Pharmaceutical
QHL Pharma
Selco Wirkstoffe Vertriebs GmbH
Select Botanical
TIANSHAN Pharmaceuticals
Hubei Zhongliao Chemical Co., LTD
Tiansheng Pharmaceutical
Sophocarpidine Segment by Type
High Purity
Low Purity
Sophocarpidine Segment by Application
Pharmaceuticals
Pesticides
Others
Sophocarpidine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sophocarpidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sophocarpidine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sophocarpidine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sophocarpidine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sophocarpidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- High Purity
- Low Purity
Applications
- Pharmaceuticals
- Pesticides
- Others
Companies covered
- Fujie Pharmaceutical
- Indena
- Jiangsu Tiansheng Pharmaceutical
- QHL Pharma
- Selco Wirkstoffe Vertriebs GmbH
- Select Botanical
- TIANSHAN Pharmaceuticals
- Hubei Zhongliao Chemical Co., LTD
- Tiansheng Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sophocarpidine Market Size (2021-2032)
- 2.2.2 Global Sophocarpidine Sales (2021-2032)
- 2.2.3 Global Sophocarpidine Market Average Price (2021-2032)
- 2.3 Sophocarpidine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 High Purity
- 2.3.3 Low Purity
- 2.4 Sophocarpidine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Pesticides
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sophocarpidine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sophocarpidine Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Sophocarpidine Revenue of Manufacturers (2021-2026)
- 3.4 Global Sophocarpidine Average Price by Manufacturers (2021-2026)
- 3.5 Global Sophocarpidine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sophocarpidine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sophocarpidine, Product Type & Application
- 3.8 Global Manufacturers of Sophocarpidine, Established Date
- 3.9 Global Sophocarpidine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fujie Pharmaceutical
- 4.1.1 Fujie Pharmaceutical Company Information
- 4.1.2 Fujie Pharmaceutical Business Overview
- 4.1.3 Fujie Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fujie Pharmaceutical Sophocarpidine Product Portfolio
- 4.1.5 Fujie Pharmaceutical Recent Developments
- 4.2 Indena
- 4.2.1 Indena Company Information
- 4.2.2 Indena Business Overview
- 4.2.3 Indena Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Indena Sophocarpidine Product Portfolio
- 4.2.5 Indena Recent Developments
- 4.3 Jiangsu Tiansheng Pharmaceutical
- 4.3.1 Jiangsu Tiansheng Pharmaceutical Company Information
- 4.3.2 Jiangsu Tiansheng Pharmaceutical Business Overview
- 4.3.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
- 4.3.5 Jiangsu Tiansheng Pharmaceutical Recent Developments
- 4.4 QHL Pharma
- 4.4.1 QHL Pharma Company Information
- 4.4.2 QHL Pharma Business Overview
- 4.4.3 QHL Pharma Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 QHL Pharma Sophocarpidine Product Portfolio
- 4.4.5 QHL Pharma Recent Developments
- 4.5 Selco Wirkstoffe Vertriebs GmbH
- 4.5.1 Selco Wirkstoffe Vertriebs GmbH Company Information
- 4.5.2 Selco Wirkstoffe Vertriebs GmbH Business Overview
- 4.5.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Portfolio
- 4.5.5 Selco Wirkstoffe Vertriebs GmbH Recent Developments
- 4.6 Select Botanical
- 4.6.1 Select Botanical Company Information
- 4.6.2 Select Botanical Business Overview
- 4.6.3 Select Botanical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Select Botanical Sophocarpidine Product Portfolio
- 4.6.5 Select Botanical Recent Developments
- 4.7 TIANSHAN Pharmaceuticals
- 4.7.1 TIANSHAN Pharmaceuticals Company Information
- 4.7.2 TIANSHAN Pharmaceuticals Business Overview
- 4.7.3 TIANSHAN Pharmaceuticals Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 TIANSHAN Pharmaceuticals Sophocarpidine Product Portfolio
- 4.7.5 TIANSHAN Pharmaceuticals Recent Developments
- 4.8 Hubei Zhongliao Chemical Co., LTD
- 4.8.1 Hubei Zhongliao Chemical Co., LTD Company Information
- 4.8.2 Hubei Zhongliao Chemical Co., LTD Business Overview
- 4.8.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Portfolio
- 4.8.5 Hubei Zhongliao Chemical Co., LTD Recent Developments
- 4.9 Tiansheng Pharmaceutical
- 4.9.1 Tiansheng Pharmaceutical Company Information
- 4.9.2 Tiansheng Pharmaceutical Business Overview
- 4.9.3 Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
- 4.9.5 Tiansheng Pharmaceutical Recent Developments
5 Global Sophocarpidine Market Scenario by Region
- 5.1 Global Sophocarpidine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sophocarpidine Sales by Region: 2021-2032
- 5.2.1 Global Sophocarpidine Sales by Region: 2021-2026
- 5.2.2 Global Sophocarpidine Sales by Region: 2027-2032
- 5.3 Global Sophocarpidine Revenue by Region: 2021-2032
- 5.3.1 Global Sophocarpidine Revenue by Region: 2021-2026
- 5.3.2 Global Sophocarpidine Revenue by Region: 2027-2032
- 5.4 North America Sophocarpidine Market Facts & Figures by Country
- 5.4.1 North America Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sophocarpidine Sales by Country (2021-2032)
- 5.4.3 North America Sophocarpidine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Sophocarpidine Market Facts & Figures by Country
- 5.5.1 Europe Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sophocarpidine Sales by Country (2021-2032)
- 5.5.3 Europe Sophocarpidine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Sophocarpidine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sophocarpidine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sophocarpidine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sophocarpidine Market Facts & Figures by Country
- 5.7.1 South America Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sophocarpidine Sales by Country (2021-2032)
- 5.7.3 South America Sophocarpidine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Sophocarpidine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sophocarpidine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sophocarpidine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Sophocarpidine Sales by Type (2021-2032)
- 6.1.1 Global Sophocarpidine Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Sophocarpidine Sales Market Share by Type (2021-2032)
- 6.2 Global Sophocarpidine Revenue by Type (2021-2032)
- 6.2.1 Global Sophocarpidine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sophocarpidine Revenue Market Share by Type (2021-2032)
- 6.3 Global Sophocarpidine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sophocarpidine Sales by Application (2021-2032)
- 7.1.1 Global Sophocarpidine Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Sophocarpidine Sales Market Share by Application (2021-2032)
- 7.2 Global Sophocarpidine Revenue by Application (2021-2032)
- 7.2.1 Global Sophocarpidine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sophocarpidine Revenue Market Share by Application (2021-2032)
- 7.3 Global Sophocarpidine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sophocarpidine Value Chain Analysis
- 8.1.1 Sophocarpidine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sophocarpidine Production Mode & Process
- 8.2 Sophocarpidine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sophocarpidine Distributors
- 8.2.3 Sophocarpidine Customers
9 Global Sophocarpidine Analyzing Market Dynamics
- 9.1 Sophocarpidine Industry Trends
- 9.2 Sophocarpidine Industry Drivers
- 9.3 Sophocarpidine Industry Opportunities and Challenges
- 9.4 Sophocarpidine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst